Analysis Of Income And Expense [Abstract]

Luxempart - Filing #4414406

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Dividend income
50,179,000 EUR
47,364,000 EUR
Material income and expense [abstract]
Operating expense excluding cost of sales
6,569,000 EUR
6,362,000 EUR
Expenses by nature [abstract]
Classes of employee benefits expense [abstract]
Employee benefits expense
7,528,000 EUR
6,311,000 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense
99,000 EUR
923,000 EUR
Impairment loss (reversal of impairment loss) recognised in profit or loss
- EUR
544,000 EUR
Disclosure of attribution of expenses by nature to their function [text block]
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
498,727,000 EUR
- EUR
- EUR
- EUR
- EUR
498,727,000 EUR
- EUR
156,695,000 EUR
- EUR
- EUR
156,695,000 EUR
- EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
498,727,000 EUR
156,695,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.